Michael Henry, MD is the Director of the Electroconvulsive Therapy (ECT) Service at Mass General, Medical Director of the Dauten Family Center for Bipolar Treatment Innovation, and an Associate Professor of Psychiatry at Harvard Medical School. His clinical work and research has focused on the management of treatment-refractory depression.
-
In this prospective observational study, neuroimaging was used to study the neurobiological correlates of ECT or rTMS in patients with treatment refractory depression. -
In this book, Dr. Michael Henry explains how new strategies for treating depression, including TMS, ketamine, and psychedelics, take advantage of the brain’s plasticity and […] -
Electroconvulsive therapy is highly effective for the treatment of depression in adolescents and is associated with a significant reduction in suicidal ideation.